DCF Advisers, LLC

Position in EVO — Evotec SE

CIK 1802493 MOUNT PLEASANT, SC

Position in EVO

as of Jun 30, 2026 · filed Aug 10, 2026 Compact

Position Value

$3,021,267

+$358,082 QoQ

Shares Held

1,079,024

+1.3% QoQ

Ownership

0.304%

of shares outstanding

% of Portfolio

0.81%

of 13F equity value

Holder Rank

of 34 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

DCF Advisers, LLC holds $13,872,352 across 3 Drug Manufacturers - Specialty & Generic names. EVO ranks #2 (21.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TEVA	Teva Pharmaceutical Industries Ltd	254,500	$8,622,460
2	EVO	Evotec SE This page	1,079,024	$3,021,267
3	LFCR	Lifecore Biomedical, Inc. De	424,500	$2,228,625

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,021,267	1,079,024	+1.3%	Shares	Sole	2026-08-10
2026-03-31	$2,663,185	1,065,274	-11.2%	Shares	Sole	2026-05-11
2025-12-31	$3,692,898	1,198,993	0.0%	Shares	Sole	2026-02-11
2025-09-30	$4,352,344	1,198,993	+7.6%	Shares	Sole	2025-11-12
2025-06-30	$4,680,870	1,114,493	+48.3%	Shares	Sole	2025-08-12
2025-03-31	$2,510,273	751,579	+227.0%	Shares	Sole	2025-05-09
2024-12-31	$956,263	229,871	+5.9%	Shares	Sole	2025-02-11
2024-09-30	$792,250	217,055	+88.8%	Shares	Sole	2024-11-13
2024-06-30	$551,774	114,953	+140.5%	Shares	Sole	2024-08-12
2024-03-31	$374,250	47,797	0.0%	Shares	Sole	2024-05-15
2023-12-31	$560,658	47,797	-2.5%	Shares	Sole	2024-02-13
2023-09-30	$484,093	49,047	+14.8%	Shares	Sole	2023-11-13
2023-06-30	$482,939	42,738	+245.0%	Shares	Sole	2023-08-09
2023-03-31	$129,454	12,388	—	Shares	Sole	2023-05-15
No filing history on record for this holder in this stock.